Monday, August 31, 2026

Invesco Pennsylvania Value Municipal Income Trust And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

August 12, 2021

Invesco Pennsylvania Value Municipal Income Trust And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Invesco Pennsylvania Value Municipal Income Trust (VPV), Calamos Global Dynamic Income Fund (CHW), Banco Bradesco (BBD) are the highest payout ratio stocks on this list.

We have gathered information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Invesco Pennsylvania Value Municipal Income Trust (VPV)

395.47% Payout Ratio

Invesco Pennsylvania Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd.

Volume

Today's last reported volume for Invesco Pennsylvania Value Municipal Income Trust is 20714, 45.5% below its average volume of 38014.

As claimed by Morningstar, Inc., the next dividend payment is on Mar 13, 2018, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 4.41%.

Year-on-year quarterly revenue growth declined by 14.2%, now sitting on 20.41M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.06%.

Invesco Pennsylvania Value Municipal Income Trust's Stock Yearly Top and Bottom Value

Invesco Pennsylvania Value Municipal Income Trust's stock is valued at $13.62 at 02:23 EST, under its 52-week high of $13.65 and way higher than its 52-week low of $11.80.

Invesco Pennsylvania Value Municipal Income Trust's Moving Average

Invesco Pennsylvania Value Municipal Income Trust's worth is above its 50-day moving average of $13.42 and higher than its 200-day moving average of $13.11.

2. Calamos Global Dynamic Income Fund (CHW)

86.6% Payout Ratio

Calamos Global Dynamic Income Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC.

Volume

Today's last reported volume for Calamos Global Dynamic Income Fund is 119948, 8.65% below its average volume of 131319.

According to Morningstar, Inc., the next dividend payment is on Jun 10, 2021, the estimated forward annual dividend rate is 0.84 and the estimated forward annual dividend yield is 7.71%.

Year-on-year quarterly revenue growth declined by 42.3%, now sitting on 16.47M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.87%.

Volatility

Calamos Global Dynamic Income Fund's last day, week, and month's current volatility was 0.09%, 0.42%, and 0.99%, respectively.

Calamos Global Dynamic Income Fund's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.84% (day), 1.26% (last week), and 1.91% (last month), respectively.

Calamos Global Dynamic Income Fund's Stock Yearly Top and Bottom Value

Calamos Global Dynamic Income Fund's stock is valued at $10.98 at 02:23 EST, under its 52-week high of $11.39 and way above its 52-week low of $7.74.

Calamos Global Dynamic Income Fund's Moving Average

Calamos Global Dynamic Income Fund's value is under its 50-day moving average of $10.98 and higher than its 200-day moving average of $10.47.

3. Banco Bradesco (BBD)

36.84% Payout Ratio

Volume

Today's last reported volume for Banco Bradesco is 22103700, 10.73% below its average volume of 24761800.

According to Morningstar, Inc., the next dividend payment is on Aug 2, 2021, the estimated forward annual dividend rate is 0.04 and the estimated forward annual dividend yield is 0.97%.

Banco Bradesco's sales growth this year is expected to be 3.3% and 9.2% for next year.

Year-on-year quarterly revenue growth grew by 61.3%, now sitting on 91.33B for the twelve trailing months.

Banco Bradesco's sales growth is 18.1% for the present quarter and negative 1.8% for the next. The company's growth estimates for the present quarter and the next is 71.4% and 20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.04%.

Volatility

Banco Bradesco's last day, week, and month's current volatility was 0.22%, 1.51%, and 1.49%, respectively.

Banco Bradesco's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.01% (day), 3.29% (last week), and 3.20% (last month), respectively.

Banco Bradesco's Stock Yearly Top and Bottom Value

Banco Bradesco's stock is valued at $4.51 at 02:23 EST, way below its 52-week high of $5.70 and way higher than its 52-week low of $3.36.

Banco Bradesco's Moving Average

Banco Bradesco's value is below its 50-day moving average of $4.82 and below its 200-day moving average of $4.71.

4. Moelis & Company (MC)

36.27% Payout Ratio

Moelis & Company, an investment bank, provides strategic and financial advisory services in the United States and internationally.

Volume

Today's last reported volume for Moelis & Company is 270808, 34.44% below its average volume of 413114.

As claimed by Morningstar, Inc., the next dividend payment is on Jul 29, 2021, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 4%.

Moelis & Company's sales growth this year is expected to be 16.6% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 125.7%, now sitting on 1.25B for the twelve trailing months.

Moelis & Company's sales growth is 79.1% for the current quarter and 24.4% for the next. The company's growth estimates for the current quarter and the next is 827.3% and 37%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 98.29%.

Volatility

Moelis & Company's last day, week, and month's current volatility was 0.87%, 0.91%, and 1.49%, respectively.

Moelis & Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.03% (day), 2.31% (last week), and 3.14% (last month), respectively.

Moelis & Company's Stock Yearly Top and Bottom Value

Moelis & Company's stock is valued at $60.04 at 02:23 EST, under its 52-week high of $60.68 and way higher than its 52-week low of $30.48.

Moelis & Company's Moving Average

Moelis & Company's value is above its 50-day moving average of $56.63 and above its 200-day moving average of $54.72.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com